Log In
Print
BCIQ
Print
Print this Print this
 

Privigen

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
Description10% formulation of IV immunoglobulin (IVIg)
Molecular Target Fc gamma receptor IIb (CD32B) (FCGR2B)
Mechanism of ActionImmune modulation
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today